Document:

Exhibit 10.1

 

RESTRUCTURING AGREEMENT

 

This Restructuring
Agreement (this “Agreement”) is entered into effective as of March 31, 2014, by and among Aethlon Medical, Inc., a
Nevada corporation (the “Company”), and the Ellen R. Weiner Family Revocable Trust (the “Holder”).

 

WHEREAS, the Company
and the Holder are parties to that certain Amended and Restated 12% Series A Convertible Promissory Note executed on June 14, 2010
(the “Note”);

 

WHEREAS, the Company
issued to the Holder certain Amended and Restated Class A Principal Common Stock Purchase Warrants, Amended and Restated Class
A Common Stock Purchase Warrants, Amended and Restated Class A-1 Common Stock Purchase Warrants and Class B Common Stock Purchase
Warrants in connection with the Note (collectively, the “Existing Warrants”;

 

WHEREAS, the Company
and the Holder desire to restructure their agreement with respect to the Note and the Existing Warrants.

 

NOW, THEREFORE, in
consideration of the mutual promises and covenants contained in this Agreement, the parties hereto agree as follows:

 

1.Conversion
of Note. Concurrently with the execution hereof, the Holder shall surrender the Note and submit a Conversion Notice, in the
form attached hereto as Exhibit A, for the conversion of all principal currently outstanding under the Note, in the amount
of $660,000, into shares of common stock of the Company (“Common Stock”). Within 5 days thereafter, the Company shall
instruct its transfer agent to issue an aggregate of 15,714,286 shares of Common Stock to the Holder in conversion of the Note.
Upon such conversion, the Note shall be of no further force or effect.

 

2.Payment and
Waiver of Interest on Note. The Company shall pay the Holder all interest that has accrued under the Note through March 31,
2014 but has not been paid. Interest through February 28, 2013 will be paid in units at a rate of $.042 per unit, with each unit
consisting of one share of Common Stock and one Common Stock Purchase Warrant, in the form attached hereto as Exhibit B,
to purchase a share of Common Stock at an exercise price of $.042 per share. Interest from March 1, 2013 through March 31, 2014
will be paid in units at a rate of $.072 per unit, with each unit consisting of one share of Common Stock and one-half Common Stock
Purchase Warrant, in the form attached hereto as Exhibit B, to purchase a share of Common Stock at an exercise price of
$.108 per share. Such interest will be paid as follows:

 

	Period of Accrual	Amount of Interest	Price per Unit	Number of Shares of Common Stock	Number of Warrant Shares
	Through February 28, 2013	$286,000	$.042	6,809,524	6,809,524
	March 1, 2013 through March 31, 2014	$57,200	$.072	794,444	397,222
	TOTAL	$343,200	 	7,603,968	7,206,746

 

    	1

    	 

    

 

Within 5 days after the execution hereof,
the Company shall instruct its transfer agent to issue the shares of Common Stock to be issued to the Holder as set forth above
and shall deliver the Warrants as set forth above. The Holder hereby waives any right to receive interest on the Note for any period
subsequent to March 31, 2014.

 

3.Amendment
of Warrants.

 

a.Adjustment
of Exercise Price. The Exercise Price, as defined in each of the Existing Warrants, shall be $.042.

 

b.Waiver
of Anti-Dilution Rights. To the extent that any Existing Warrant contains any provision that would act to reduce the exercise
price of such Existing Warrant if the Company were to issue any Common Stock, other than excepted issuances specified in the applicable
Existing Warrant (“Excepted Issuances”), at a price below such exercise price, the Holder hereby agrees that such Existing
Warrant hereby is amended to remove such anti-dilution protection and, until such Existing Warrant is no longer outstanding, the
Company shall be prohibited from issuing any Common Stock or securities convertible into or exercisable for shares of Common Stock
(or modifying, with equivalent effect, any of the foregoing that may be outstanding), other than Excepted Issuances, at a price
below $.042.

 

c.Expiration
Date of Existing Warrants. The “Expiration Date,” as defined in each of the Existing Warrants, shall be July 1,
2018.

 

4.Restructuring
Fee. In connection with the restructuring effected by this Agreement, the Company shall pay the Holder a restructuring fee
of 75,000 shares of Common Stock. Within 5 days after the execution hereof, the Company shall instruct its transfer agent to issue
such shares to the Holder.

 

5.Legends.
The Holder understands that (i) the Company will issue the securities to be issued hereunder without registering such securities
under the Securities Act of 1933, as amended (the “Act”), or the applicable securities laws of any state in reliance
on exemptions from registration and (ii) such exemptions depend on the Holder’s investment intent at the time of the Holder’s
acquisition of such securities. Accordingly, the Holder represents and warrants that it is acquiring such securities for the Holder’s
own account for investment only and not with a view to distribution thereof. The Holder acknowledges that the Holder must hold
such securities indefinitely unless they are registered under the Act and any applicable state securities laws or an exemption
from registration is applicable. The shares of Common Stock to be issued hereunder and upon exercise of the Warrants to be issued
hereunder shall bear a legend in substantially the following form:

 

THE SHARES OF COMMON STOCK REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDE THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE
STATE SECURITIES LAWS, AND THEY MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE ACT AND UNDER ANY APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE
COMPANY, THAT AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.

 

    	2

    	 

    

 

In addition, the Company may direct its
transfer agent to note in its records with respect to the shares of Common Stock to be issued hereunder that the Holder may be
deemed to be an affiliate of the Company.

 

6.Waiver of
Limitation on Conversion or Exercise Rights. The Company and the Holder waive compliance with any provision contained in any
security held by the Holder that would limit the number of shares of Common Stock that the Holder may be deemed to own beneficially.

 

7.Waiver and
Release. Except as set forth herein, the Holder hereby waives any further rights it may have against the Company under or in
connection with the Note and hereby releases the Company from any further obligations under or in connection with the Note.

 

8.Miscellaneous.

 

a.Amendments
and Waivers. The provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents to departures
from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holder.

 

b.Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as
set forth in the Holder’s Existing Warrants.

 

c.Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each
of the parties.

 

d.Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed will be deemed to be an original and,
all of which taken together will constitute one and the same Agreement. In the event that any signature is delivered by facsimile
transmission, such signature will create a valid binding obligation of the party executing (or on whose behalf such signature is
executed) the same with the same force and effect as if such facsimile signature were the original thereof.

 

e.Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed
by and construed and enforced in accordance with the internal laws of the State of California, without regard to principles of
conflicts of law that would result in the application of the law of another jurisdiction. Each party hereby irrevocably submits
to the exclusive jurisdiction of the state and federal courts sitting in the City of San Diego, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. If either
party shall commence a proceeding to enforce any provisions of this Agreement, then the prevailing party in such proceeding shall
be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such proceeding.

 

    	3

    	 

    

 

f.Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term,
provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have
executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

 

[Signature page follows]

 

 

 

 

 

 

    	4

    	 

    

 

IN WITNESS WHEREOF, the parties have executed
this Restructuring Agreement as of the date first written above.

 

AETHLON MEDICAL, INC.

 

 

 

                                                                           

Name: James A. Joyce

Title: Chief Executive
Officer

 

 

Ellen R. Weiner Family Revocable
Trust

 

 

                                                                           

 

By:                                                                      

Its: Trustee

 

    	5

    	 

    

 

EXHIBIT A

 

CONVERSION NOTICE

 

 

(To be signed only upon conversion of this
Note)

 

 

TO: AETHLON MEDICAL, INC.

 

The undersigned, the registered holder
of the Amended and Restated 12 % Series A Convertible Note (the "Note") of AETHLON MEDICAL, INC. (the "Company"),
hereby surrenders the Note for conversion into shares of Common Stock of the Company (the "Common Stock") to the extent
of $660,000.00 unpaid principal amount of the Note and unpaid accrued Interest due under the Note, all in accordance with the provisions
of such Note. The undersigned requests that a certificate representing the shares, bearing the appropriate legends, be issued to
the undersigned.

 

ELLEN R. WEINER FAMILY REVOCABLE TRUST

 

 

 

By: _____________________________________

(Signature and name
of the registered holder)

 

________________________________________

Print Name

 

________________________________________

Print Title

 

Dated:___________________________________

 

 

    	6

    	 

    

 

 

EXHIBIT B

 

COMMON STOCK PURCHASE WARRANT

 

 

 

 

 

 

 

    	7Exhibit 10.2

 

RESTRUCTURING AGREEMENT

 

This Restructuring
Agreement (this “Agreement”) is entered into effective as of March 31, 2014, by and among Aethlon Medical, Inc., a
Nevada corporation (the “Company”), and ____________________ (the “Holder”).

 

WHEREAS, the Company
and the Holder were parties to that certain Amended and Restated 12% Series A Convertible Promissory Note executed on June 14,
2010 (the “Note”);

 

WHEREAS, the Company
issued to the Holder certain Amended and Restated Class A Principal Common Stock Purchase Warrants, Amended and Restated Class
A Common Stock Purchase Warrants, Amended and Restated Class A-1 Common Stock Purchase Warrants and Class B Common Stock Purchase
Warrants in connection with the Note (collectively, the “Existing Warrants”);

 

WHEREAS, the Company
and the Holder desire to restructure their agreement with respect to the Existing Warrants.

 

NOW, THEREFORE, in
consideration of the mutual promises and covenants contained in this Agreement, the parties hereto agree as follows:

 

1.Amendment
of Warrants.

 

a.Adjustment
of Exercise Price. The Exercise Price, as defined in each of the Existing Warrants, shall be $.042.

 

b.Waiver
of Anti-Dilution Rights. To the extent that any Existing Warrant contains any provision that would act to reduce the exercise
price of such Existing Warrant if the Company were to issue any Common Stock, other than excepted issuances specified in the applicable
Existing Warrant (“Excepted Issuances”), at a price below such exercise price, the Holder hereby agrees that such Existing
Warrant hereby is amended to remove such anti-dilution protection and, until such Existing Warrant is no longer outstanding, the
Company shall be prohibited from issuing any Common Stock or securities convertible into or exercisable for shares of Common Stock
(or modifying, with equivalent effect, any of the foregoing that may be outstanding), other than Excepted Issuances, at a price
below $.042.

 

c.Expiration
Date of Existing Warrants. The Expiration Date, as defined in each of the Existing Warrants, shall be July 1, 2018.

 

2.Miscellaneous.

 

a.Amendments
and Waivers. The provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents to departures
from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holder.

 

    	1

    	 

    

 

b.Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as
set forth in the Holder’s Existing Warrants.

 

c.Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each
of the parties.

 

d.Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed will be deemed to be an original and,
all of which taken together will constitute one and the same Agreement. In the event that any signature is delivered by facsimile
transmission, such signature will create a valid binding obligation of the party executing (or on whose behalf such signature is
executed) the same with the same force and effect as if such facsimile signature were the original thereof.

 

e.Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed
by and construed and enforced in accordance with the internal laws of the State of California, without regard to principles of
conflicts of law that would result in the application of the law of another jurisdiction. Each party hereby irrevocably submits
to the exclusive jurisdiction of the state and federal courts sitting in the City of San Diego, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. If either
party shall commence a proceeding to enforce any provisions of this Agreement, then the prevailing party in such proceeding shall
be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such proceeding.

 

f.Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term,
provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have
executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

 

[Signature page follows]

 

 

    	2

    	 

    

 

IN WITNESS WHEREOF, the parties have executed
this Restructuring Agreement as of the date first written above.

 

AETHLON MEDICAL, INC.

 

 

 

______________________________________

 

Name: James A. Joyce

Title: Chief Executive
Officer

 

 

 

 

______________________________________

 

 

 

    	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]